These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


186 related items for PubMed ID: 1342692

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Plasminogen activators and cancer.
    Duffy MJ.
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):681-7. PubMed ID: 2133247
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Plasmin/plasminogen system in colorectal cancer.
    Berger DH.
    World J Surg; 2002 Jul; 26(7):767-71. PubMed ID: 11965442
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Role of plasminogen activators in the development of tumors and the process of their metastasis].
    Liaginskiĭ AV, Egorov BB.
    Vopr Onkol; 1989 Jul; 35(12):1418-25. PubMed ID: 2692282
    [No Abstract] [Full Text] [Related]

  • 8. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.
    Tuck AB, Arsenault DM, O'Malley FP, Hota C, Ling MC, Wilson SM, Chambers AF.
    Oncogene; 1999 Jul 22; 18(29):4237-46. PubMed ID: 10435636
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Plasminogen activators in tumor tissue].
    Tomasiuk R, Mirowski M, Wierzbicki R.
    Pol Arch Med Wewn; 1989 Jun 22; 81(6):355-63. PubMed ID: 2517455
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T.
    BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015
    [Abstract] [Full Text] [Related]

  • 16. Proteolytic enzymes in proliferation and neoplastic metastases formation.
    Gołaszewski Z, Gacko M, Chyczewska E, Chyczewski L, Myćko G, Worowski K.
    Rocz Akad Med Bialymst; 1997 Feb 20; 42 Suppl 1():48-59. PubMed ID: 9337523
    [Abstract] [Full Text] [Related]

  • 17. Tumoral vascularity as a prognostic factor in cancer.
    Weidner N, Folkman J.
    Important Adv Oncol; 1996 Feb 20; ():167-90. PubMed ID: 8791135
    [No Abstract] [Full Text] [Related]

  • 18. [Role of single chain pro-UK on the initiation and regulation of fibrinolysis].
    Arimura H, Kasai S, Nishida M, Suyama T.
    Rinsho Byori; 1989 Apr 20; Spec No 81():107-17. PubMed ID: 2502639
    [No Abstract] [Full Text] [Related]

  • 19. Identification of markers of possible prognostic value in 57 giant cell tumors of bone.
    Gamberi G, Serra M, Ragazzini P, Magagnoli G, Pazzaglia L, Ponticelli F, Ferrari C, Zanasi M, Bertoni F, Picci P, Benassi MS.
    Oncol Rep; 2003 Apr 20; 10(2):351-6. PubMed ID: 12579271
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.